financetom
Business
financetom
/
Business
/
Citigroup Banamex Deal Raises Profitability, Capital Questions, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citigroup Banamex Deal Raises Profitability, Capital Questions, UBS Says
Sep 29, 2025 12:27 PM

02:55 PM EDT, 09/29/2025 (MT Newswires) -- Citigroup ( C ) plans to sell a 25% stake in Banamex to a private investor at 0.8x book value, raising questions about the unit's profitability, IPO prospects, and common equity tier 1 allocation, UBS Securities said in a note Monday.

The firm noted that Banamex has long struggled with profitability, with its return on equity declining from around 19% in 2004 to 2007 to an average of just 9.5% between 2012 and mid-2025, according to the report.

Despite low profitability, UBS noted Banamex's strong operating income-to-assets ratio of 10.3% versus 7.4% for peers and a higher CET1 ratio of 17.9% versus 16.3%, with H1 earnings of $483 million, annualized to $966 million, about 5% of Citigroup's ( C ) 2027 consensus net income.

The bank's cost base also looks heavy, with expenses-to-assets at 6.3% versus 2.4% for peers, the brokerage said, adding that efficiency measures could provide a quicker route to improving returns.

The partial sale may free around $8.2 billion, or 4% of Citigroup's ( C ) market cap, enhancing buyback capacity, while cost optimization could help boost return on equity, key for initial public offering investor appeal, UBS added.

The firm has a neutral rating on the stock.

Price: 103.28, Change: -0.14, Percent Change: -0.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Quest Diagnostics To Acquire LifeLabs From OMERS, Enhancing Diagnostic Services For Canadians
BRIEF-Quest Diagnostics To Acquire LifeLabs From OMERS, Enhancing Diagnostic Services For Canadians
Jul 3, 2024
July 3 (Reuters) - Quest Diagnostics Inc ( DGX ): * QUEST DIAGNOSTICS TO ACQUIRE LIFELABS FROM OMERS, ENHANCING DIAGNOSTIC SERVICES FOR CANADIANS * QUEST DIAGNOSTICS INC ( DGX ): PROPOSED DEAL FOR CAN $1.35 BILLION * QUEST DIAGNOSTICS INC ( DGX ) - TO ACQUIRE LIFELABS FOR CAN $1.35 BILLION * QUEST DIAGNOSTICS INC ( DGX ) - TRANSACTION...
Sector Update: Consumer Stocks Advance Premarket Wednesday
Sector Update: Consumer Stocks Advance Premarket Wednesday
Jul 3, 2024
09:10 AM EDT, 07/03/2024 (MT Newswires) -- Consumer stocks were advancing premarket Wednesday, with the Consumer Discretionary Select Sector SPDR Fund ( XLY ) 0.3% higher and the Consumer Staples Select Sector SPDR Fund ( XLP ) up 0.1%. D-MARKET Electronic Services & Trading (HEPS) shares were up over 5% after the company launched a cargo distribution service in certain...
--Stellantis Partners with France's CEA to Build Next-Generation Battery Cells for EVs
--Stellantis Partners with France's CEA to Build Next-Generation Battery Cells for EVs
Jul 3, 2024
09:07 AM EDT, 07/03/2024 (MT Newswires) -- Price: 19.70, Change: +0.04, Percent Change: +0.20 ...
PennyMac Mortgage Investment Trust Prices $355 Million Secured Term Notes
PennyMac Mortgage Investment Trust Prices $355 Million Secured Term Notes
Jul 3, 2024
09:11 AM EDT, 07/03/2024 (MT Newswires) -- PennyMac Mortgage Investment Trust ( PMT ) said Wednesday $355 million private offering of secured term notes through its PMT Issuer Trust - FSMR unit were priced at the secured overnight financing rate +2.75%. The company said proceeds from the offering, which mature on Dec. 27, 2027, will be used to redeem $305...
Copyright 2023-2026 - www.financetom.com All Rights Reserved